• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

In Vivo Platelet Activation in Critically-Ill Patients with Primary H1N1 Influenza

tetano

Editor, Senior Moderator
Chest. 2012 Mar 1. [Epub ahead of print]
In Vivo Platelet Activation in Critically-Ill Patients with Primary H1N1 Influenza.
Rondina MT, Brewster B, Grissom CK, Zimmerman GA, Kastendieck DH, Harris ES, Weyrich AS.
Source

1Divisions of General Internal Medicine and.
Abstract

Structured AbstractBackgroundChanges in platelet reactivity during H1N1 influenza have not been characterized.MethodsWe prospectively examined platelet activation and cytokine responses in H1N1 influenza patients (n=20), matched patients with bacterial pneumonia (n=15), and non-hospitalized, healthy control subjects (n=10).ResultsPlatelet-monocyte aggregation was higher in H1N1 patients (21.4?4.7%) compared to pneumonia (10.9?3.7%) and control subjects (8.1?4.5%, p<0.05). Similarly, PAC-1 binding to platelets is increased in H1N1 patients (9.5?4.7%) compared to patients with pneumonia (1.0?0.7%) and healthy subjects (0.61?0.15%, p<0.10). PAC-1 binding was two-fold higher in H1N1 patients with shock versus those without shock. Interleukin-6 (IL-6) levels were elevated in H1N1 patients indicating systemic inflammation consistent with activation of circulating platelets.ConclusionsThese findings, derived from a small but documented cohort of patients, demonstrate that platelet activation responses during H1N1 influenza are enhanced - exceeding responses in patients with bacterial pneumonia - and provide new evidence that platelets may contribute to inflammatory responses during H1N1 influenza.

PMID:
22383669
[PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/22383669
 
Back
Top Bottom